We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

127 hedge funds and large institutions have $783M invested in Arcturus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 28

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

64% more call options, than puts

Call options by funds: $27M | Put options by funds: $16.5M

29% more capital invested

Capital invested by funds: $606M → $783M (+$177M)

11.48% more ownership

Funds ownership: 63.2% → 74.68% (+11%)

11% more funds holding

Funds holding: 114 → 127 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
127
Holders Change
+13
Holders Change %
+11.4%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
33
Increased
54
Reduced
28
Closed
20
Calls
$27M
Puts
$16.5M
Net Calls
+$10.6M
Net Calls Change
+$14.5M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$74.5M
2
State Street
State Street
Massachusetts
+$64.6M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$37.8M
4
AIM
ARK Investment Management
Florida
+$28.6M
5
O
OrbiMed
New York
+$18.8M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$25.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$19.3M
3
Invesco
Invesco
Georgia
-$10.5M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$10.4M
5
CH
CVI Holdings
Delaware
-$9.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
OIA
126
Optimum Investment Advisors
Illinois
$1K +$1.09K +22 New
EI
127
Ellevest Inc
New York
$1K +$1.49K +30 New
Point72 Asset Management
128
Point72 Asset Management
Connecticut
– -$10.4M -223,013 Closed
CH
129
CVI Holdings
Delaware
– -$9.35M -200,032 Closed
Adage Capital Partners
130
Adage Capital Partners
Massachusetts
– -$4.67M -100,000 Closed
MIM
131
Monashee Investment Management
Massachusetts
– -$3.72M -79,497 Closed
Acadian Asset Management
132
Acadian Asset Management
Massachusetts
– -$2.6M -55,642 Closed
EI
133
EAM Investors
California
– -$1.9M -40,695 Closed
EGI
134
EAM Global Investors
California
– -$1.45M -30,948 Closed
QI
135
QS Investors
New York
– -$1.07M -22,900 Closed
EGM
136
Engineers Gate Manager
New York
– -$756K -16,164 Closed
Millennium Management
137
Millennium Management
New York
– -$293K -6,276 Closed
D.E. Shaw & Co
138
D.E. Shaw & Co
New York
– -$275K -5,874 Closed
TSS
139
Two Sigma Securities
New York
– -$263K -5,618 Closed
FAM
140
Formidable Asset Management
Ohio
– -$263K -4,866 Closed
Squarepoint
141
Squarepoint
New York
– -$224K -4,796 Closed
AC
142
Athanor Capital
New York
– -$224K -4,791 Closed
Tudor Investment Corp
143
Tudor Investment Corp
Connecticut
– -$203K -4,346 Closed
HIIFS
144
Harel Insurance Investments & Financial Services
Israel
– -$37K -800 Closed
VFA
145
Valeo Financial Advisors
Indiana
– -$10K -205 Closed
Simplex Trading
146
Simplex Trading
Illinois
– -$4.17K -84 Closed
RWB
147
RMR Wealth Builders
New Jersey
– -$1K -28 Closed
2 3 4 5
6

ARCT Hedge Fund Activity: Q3 2020 in Review

127 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q3 2020, worth a combined $783M — up 29% from $606M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ARCT positions and 20 closed out — a net gain of 13 holders — while 54 added to existing stakes and 28 trimmed.

The largest buyer was HealthCor Management, adding an estimated $74.5M. The largest seller was Deutsche Bank, cutting an estimated $25.4M.

  • 127 institutional investors held Arcturus Therapeutics (ARCT) as of Q3 2020, up from 114 in Q2 2020.
  • Funds reported $783M of Arcturus Therapeutics stock for Q3 2020, up 29% quarter-over-quarter.
  • 33 funds opened new Arcturus Therapeutics positions in Q3 2020 and 20 closed out, a net change of +13 holders.
  • The largest Arcturus Therapeutics buyer in Q3 2020 was HealthCor Management, an estimated $74.5M added.
  • The largest Arcturus Therapeutics seller in Q3 2020 was Deutsche Bank, an estimated $25.4M sold.

Based on aggregated 13F filings for Q3 2020.